Sam Pendleton
Story Poster
Notre Dame relying on new additions to replicate success of 2024
2 mo ago by Olin Buchanan
Notre Dame must replace its quarterback, three starting offensive linemen, two of its top receivers, its top two tacklers and its leader in sacks and interceptions. Even with so many departures, Marcus Freeman's Fighting Irish are projected to be a top-10 team.
Story Poster
Detailing important departures from Texas A&M's top 2025 opponents
5 mo ago by Olin Buchanan
As Mike Elko & Co. prepare for the 2025 football season, Olin Buchanan takes a deep dive into the losses that some of Texas A&M's biggest opponents are facing due to players' completion of eligibility, early entry to the NFL draft and those entering the transfer portal.
Story Poster
New lines likely the difference on Saturday as A&M begins a new era
11 mo ago by Olin Buchanan
Mike Elko represents a new hope for Texas A&M football, but in Saturday's opener against No. 7 Notre Dame, it will likely be the new offensive lines that will decide who emerges victoriously. The "Elko Era" officially kicks off at 6:30 p.m. CT from Kyle Field in Bryan-College Station.
Story Poster
19:25
Nuño's Notes: Sharing South Bend intel from Notre Dame insiders
11 mo ago by David Nuño
Marcus Freeman's Notre Dame Fighting Irish enter the 2024 season ranked No. 7 in the nation and with CFP hopes. After speaking to some Notre Dame insiders, David Nuño shares some of the intel coming from South Bend as the Irish come to Aggieland this week.
Story Poster
30:50
Elko confident a 'No. 1' receiver will emerge as Aggies open season
11 mo ago by Olin Buchanan
The departures of Ainias Smith and Evan Stewart have casted doubt over the strength of Texas A&M's receiving corps, particularly, whether or not a "No. 1" receiver will rise. Ahead of Saturday's season opener, Mike Elko expressed belief that he does have a go-to wideout.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.